LataMed AI Reports Growing Industry Interest in Integrated Digital Health Platforms Following HLTH Europe 2026

LataMed AI Corp. (OTC: LMED), a development-stage digital health and artificial intelligence technology company, provided an update on its participation at HLTH Europe 2026, a major healthcare innovation conference. The company emphasized that the event reinforced the growing industry demand for integrated digital health solutions that address patient accessibility, care coordination, and operational efficiency.

Management stated that HLTH Europe provided a platform to engage with healthcare innovators, technology firms, providers, insurers, and digital health organizations from Europe, Latin America, and other regions. The conference allowed LataMed to increase awareness of its developing healthcare technology platform among a broad range of industry participants. The company believes that engagement with global stakeholders is a crucial component of its long-term strategy to build an integrated healthcare ecosystem in Latin America.

Key themes observed at the conference include a heightened interest in artificial intelligence applications, telehealth infrastructure, healthcare payments, insurance accessibility, and technology-enabled patient engagement. LataMed noted that these trends align closely with its ongoing efforts to develop a platform that combines telehealth, care coordination, payment accessibility, insurance integration, pharmacy services, and AI-driven analytics.

Dr. Kevin Rodan Levy, CEO of LataMed AI, commented: “HLTH Europe provided an outstanding opportunity to engage with healthcare and technology professionals from across Europe, Latin America, and other international markets. One of the most encouraging takeaways was the growing industry focus on integrated healthcare platforms that combine accessibility, coordination, financial solutions, and technology-enabled patient engagement. We believe many of these trends align closely with the direction of our broader healthcare ecosystem strategy and reinforce our long-term vision.”

Dr. Levy further noted that the conference provided valuable visibility for the company’s platform initiatives and helped establish new industry relationships that may support future growth. The company is currently reviewing follow-up opportunities from discussions held during the conference and intends to provide updates on material developments as appropriate.

LataMed AI’s strategy centers on developing technology platforms to support healthcare access, patient engagement, provider coordination, emergency response, pharmacy integration, and data-driven operations, with an initial focus on Latin America. The company believes that the conference validated its approach and highlighted the market’s readiness for integrated digital health solutions.

Photographs and highlights from the company’s attendance at HLTH Europe 2026 are available through LataMed AI’s official Instagram page. For additional information, visit https://latamed.ai or review the company’s filings with the SEC at www.sec.gov.